Nerve Recovery Max: Questions And Answers

A dietary supplement in capsule form, sold for nerve comfort. One bottle holds 60 capsules and the label's suggested use is two capsules daily with 6–8 oz of water, so a bottle is thirty days. The Supplement Facts panel declares ten dietary ingredients, every one of them with its own printed amount — four vitamins and six other actives. There is no proprietary blend anywhere on it.

No published human trial exists on this combination, and none is claimed, so there is no evidence that answers the question directly. What can be checked is each ingredient against the dose its own trials used, and we have done that for all ten. Two land on or near a studied dose, three are full or near-full Daily Values, three have no comparison we would publish, one is a unit error, and one is a thirtieth of the threshold its review names. That is the honest state of it.

That is not a word this desk uses, because it describes intent and we cannot see intent. What we can do is report the label, and this label is better built than most: every amount is printed, there is no blend, the front-panel claims each carry a dagger that resolves to the FDA disclaimer, the capsule shell is named and the country-of-origin wording is the correct qualified one. The problems here are two specific doses and a checkout that published us no prices — not concealment.

No. It is a dietary supplement and the bottle says so. It is not a treatment for diabetic neuropathy, chemotherapy-induced neuropathy, a pinched nerve or anything else, and nothing on the pack claims it is. The three front-panel claims are structure-function phrases — healthy nerve function, the neurological system, blood flow & circulation — each daggered to the standard disclaimer that the statements have not been evaluated by the FDA.

No dietary supplement is FDA approved, and any page telling you this one is should be closed. The FDA does not approve supplements before sale. What the bottle carries is a GMPc Facility roundel — Good Manufacturing Practice, certified — which is a statement about how a facility documents its processes. It is not a test of this bottle and not an approval of anything in it.

A capsule, and a vegetable one: the other-ingredients list names hypromellose (vegetable capsule) rather than gelatin. That is the line a vegetarian buyer needs and most capsule labels leave you to guess at it. The serving is two capsules, so every figure on the panel is per two, not per one.

The brand name says Recovery. The trials behind its two best-dosed ingredients measured symptom scores — SYDNEY 2's primary outcome was a Total Symptom Score — not nerve regeneration. A brand name is positioning rather than a regulated claim, and this one reaches further than the daggered claims under it do.

No, and that is the best thing about this product. Every one of the ten dietary ingredients carries its own printed amount. Nothing is hidden inside a total, nothing has to be inferred from a listing order, and no ceiling arithmetic is needed. You can check this entire panel against published figures without leaving the label.

Per two capsules: Vitamin D3 20 mcg, Vitamin B6 1.7 mcg, Folate 383 mcg DFE (230 mcg folic acid), Vitamin B12 2 mcg, Alpha Lipoic Acid 400 mg, Benfotiamine 150 mg, Acetyl L-Carnitine 50 mg, Ashwagandha Powder (Root) 25 mg, Broccoli Powder 25 mg and Turmeric Powder (Root) 25 mg. Six of those carry **, meaning no Daily Value has been established — which is correct, because none has.

Per serving, and the serving is two capsules. This is the commonest misreading of a panel like this one. If you take one capsule you get half of every figure on it — 200 mg of alpha-lipoic acid, 75 mg of benfotiamine, and so on.

Daily Value (DV) not established. It appears beside the six non-vitamin ingredients and it is the correct flag for them: the FDA has set no Daily Value for alpha-lipoic acid, benfotiamine, acetyl-L-carnitine, ashwagandha, broccoli powder or turmeric, so there is no percentage to print. It is not a warning and it is not a criticism — it is the panel being built properly.

All four, against the Daily Values the NIH Office of Dietary Supplements publishes. Three are correct. Vitamin D3 at 20 mcg is 100% of a 20 mcg DV, exactly. Folate at 383 mcg DFE is 95.75% of 400, which rounds to the 96% printed. B12 at 2 mcg is 83.3% of 2.4, which rounds to the 83% printed. The fourth does not survive — see the next question.

The unit. The NIH's figure is unambiguous: “The DV for vitamin B6 is 1.7 mg for adults and children age 4 years and older.” The panel prints 1.7 mcg and puts 100% beside it. A microgram is a thousandth of a milligram, so 1.7 mcg is 0.1% of the Daily Value, not 100%. The two statements cannot both be true.<p>The likeliest explanation is the dullest one: a typo for mg, which would make the percentage correct and the amount an ordinary full Daily Value. We cannot print a correction as though it were the label, so we print the discrepancy and tell you which way we think it falls.</p>

We do not know, and neither does anybody reading that panel. If the unit is the typo, 1.7 mg — a full Daily Value, and nowhere near a level of concern. If the number is right and the percentage is the error, 1.7 mcg — a thousandth of a Daily Value, which is nothing. Neither reading is dangerous. Only one of them is useful, and the label does not tell you which it is.

Not the percentage — that checks out. The two figures inside the line do not reconcile with each other. The panel prints 383 mcg DFE (230 mcg folic acid), and the NIH's conversion is “mcg DFE = mcg naturally occurring folate + (1.7 x mcg folic acid).” 230 × 1.7 is 391, not 383. One of the two numbers is out by about 2%. It changes nothing clinically; we print it because we recompute everything.

It is the largest active in the capsule at 400 mg and the only ingredient on this panel that a government source names in connection with nerve symptoms. NCCIH's wording is careful: “For a few dietary supplements, there is weak evidence of a possible benefit… alpha-lipoic acid might be helpful for diabetic neuropathy (nerve problems).” Weak evidence of a possible benefit is not nothing, and it is also not a promise.

It is two-thirds of the dose the main trial recommends. SYDNEY 2 gave 181 patients 600, 1,200 or 1,800 mg once daily for five weeks and concluded that “an oral dose of 600 mg once daily appears to provide the optimum risk-to-benefit ratio.” 400 is not 600. It is the same order of magnitude, which is more than most labels in this category manage, and the trial does not tell us what two-thirds of a dose does.

The trial says not. All three doses moved the symptom score by a similar amount — “4.9 points (51%) in ALA600, 4.5 (48%) in ALA1200, and 4.7 (52%) in ALA1800” — which is exactly why the conclusion recommends the lowest of the three. Tripling the dose bought nothing. That is a useful thing to know if you are tempted to take two servings.

SYDNEY 2's own conclusion frames 600 mg as the optimum risk-to-benefit ratio, which is a phrase about risk as well as benefit. NCCIH's general warning on this category belongs here too: “some dietary supplements may have side effects, and some of these side effects, such as kidney damage, can be serious.” If you take medication for blood sugar, this is a conversation with your prescriber.

A fat-soluble form of thiamine (vitamin B1). On this panel it sits under the ** flag rather than with the vitamins, because no Daily Value has been established for benfotiamine as such. It is printed at 150 mg per serving.

It is exactly the monotherapy dose from the trial we opened. That study describes its monotherapy arm as “3 x 1 tablets/day, = 150 mg benfotiamine/day.” This label prints 150 mg. To the milligram, it is the studied figure — which is the single most unusual thing on this panel.

With two qualifications the trial makes itself. Its conclusion is that benfotiamine “is most effective in large doses”, and its high-dose arm was “320 mg benfotiamine/day” — more than twice what is here. And it was 36 patients over six weeks, twelve to an arm. The dose is right. The evidence underneath it is thin.

It is the ingredient with the most research behind it for diabetic peripheral neuropathy and the one this label gets most wrong. A Cochrane review pooled the randomised trials; they used 1,500, 2,000 and 3,000 mg a day.

No, and the review says so without being asked. Its wording is: “any effect may be present at doses greater than 1500 mg/day but not at lower doses.” 50 mg is one-thirtieth of the smallest figure in that sentence. This is not a marginal shortfall — the threshold is named by the review and the label prints a thirtieth of it.

Cochrane is cautious even at the studied doses: “We are very uncertain whether ALC causes a reduction in pain after 6 to 12 months' treatment in people with DPN… as the evidence is sparse and of low certainty.” So the honest position is that it may not work at 1,500 mg, and at 50 mg the review expects nothing.

We cannot tell you why, only what it does. An ingredient at a fraction of its studied dose still appears on the panel, still appears in the marketing list, and still lets a buyer who recognises the name assume the dose is there. This is the line we would take off this panel, and the one that costs the product most in our score.

20 mcg, which is exactly 100% of the Daily Value — the NIH's figure is “20 mcg (800 IU) for adults and children age 4 years and older.” That is also the RDA for adults over 70 and above the 15 mcg RDA for everyone from 19 to 70. There is nothing to criticise in the line. We found no source connecting vitamin D at this dose to nerve symptoms specifically, so we claim none.

Because B12 deficiency causes the symptom this product is sold for. The NIH's own wording: “Neurological changes, such as numbness and tingling in the hands and feet, can also occur”, and those changes “can occur without anemia, so early diagnosis and intervention is important.” 2 mcg is 83% of a Daily Value. If low B12 is what is causing your symptoms, that is a blood test and a conversation, not a shelf product — but it is the one mechanism on this label where a supplement could plausibly matter.

It is the single most useful question on this page. The NIH records that metformin “might reduce the absorption of vitamin B12 and significantly reduce serum vitamin B12 concentrations.” Low B12 causes numbness and tingling in the hands and feet. If you take metformin and you have those symptoms, ask for a B12 level before you buy anything. Find out which problem you have first.

At very high doses, yes — which is worth knowing on a nerve product, and worth putting in proportion. The NIH records that “chronic administration of 1–6 g oral pyridoxine per day for 12–40 months can cause severe and progressive sensory neuropathy”, and the Tolerable Upper Intake Level for adults is 100 mg a day. Neither figure is remotely close to this label, on either reading of its B6 line. This is context, not a warning about this bottle.

383 mcg DFE, which is 96% of the Daily Value. We found no source connecting folate at this dose to nerve symptoms specifically and we claim none. Note that it is delivered as folic acid — 230 mcg of it — rather than as a methylated form, which some people prefer and which is a conversation for a clinician rather than a label.

25 mg of root powder — not a standardised extract. NCCIH records that some ashwagandha preparations “may be effective for insomnia and stress” and says nothing about nerves. It also records that although rare, “there have been a number of cases that link liver injury to ashwagandha supplements.” We found no trial of ashwagandha for nerve symptoms at any dose that we would cite, so we publish no comparison for this line.

NCCIH's position on turmeric generally: “We don't know enough to definitively conclude if turmeric or curcumin is beneficial for any health purposes.” This is plain root powder rather than a bioavailable curcumin formulation, which is actually the safer choice — NCCIH notes that the highly bioavailable versions “may harm your liver.” We publish no dose comparison for it.

25 mg of broccoli leaf powder, per the panel's own parenthesis: Brassica Oleracea (leaf). We looked for a monograph, a government fact sheet or a trial covering broccoli leaf powder at any dose for nerve symptoms and found none we would cite, so we publish nothing for it. For scale, 25 mg is roughly the dry weight of a third of a gram of vegetable.

We cannot tell you why. What we can tell you is the arithmetic: three lines at 25 mg is 75 mg of the roughly 700 mg of active weight in a serving, or about a tenth of it. None of the three is a standardised extract, none carries an extract ratio or a marker-compound percentage, and we found no dose comparison for any of them.

The bottle says: As a dietary supplement, adults take two (2) capsules daily. For best results, take with 6–8 oz of water or as directed by a healthcare professional. Two capsules, with a glass of water, once a day.

The label does not say, and for this formula it matters less than usual — nothing in it is a stimulant, so there is no sleep question to plan around. Pick a time you will not miss. Nine of the ten reviews supplied with this product describe attaching it to something that already happens rather than to a clock.

Not specified beyond the 6–8 oz of water. The label gives no fasting instruction and no with-meals instruction. One of the supplied reviews says I take it with dinner so I don't miss it, which is a habit answer rather than an absorption one.

You can, and you would get half of every figure on the panel: 200 mg of alpha-lipoic acid instead of 400, 75 mg of benfotiamine instead of 150. Since benfotiamine at the full serving is exactly the trial's monotherapy dose, halving it takes the one line that matches a study and makes it not match. The label says two.

The bottle's caution says do not exceed recommended dose, and on the alpha-lipoic acid the trial gives a specific reason not to: tripling the dose from 600 to 1,800 mg did not improve the symptom score. More is not the lever here.

Take it the next day. Nothing in this formula accumulates to a level where one missed day matters, and nothing in it is a stimulant you could double up on safely. One of the supplied reviews says he skipped a holiday and noticed, which is one person's experience and not a finding.

Not published. No onset time appears on the bottle or anywhere in the pack we were given, and no trial exists on this combination to establish one. What the individual trials ran for: five weeks for alpha-lipoic acid, six weeks for benfotiamine, and six to twelve months in the acetyl-L-carnitine review. The supplied review summary says most people waited three to six weeks.

Nothing on the bottle says it, nothing in the pack we were given says it, and no source we opened supports it. We flag it because one of the ten reviews supplied with this product says in his own words that he wanted five-day relief like the headline and that it didn't happen — which means a buyer read that somewhere. If you were shown a five-day promise, it did not come from this label.

We cannot tell you that, and neither can the label. What we can do is list the specific cautions our sources record and let you take them to a clinician with the panel in your hand: liver notes on ashwagandha and on bioavailable curcumin formulations, the metformin and B12 interaction, NCCIH's general warning that supplement side effects “such as kidney damage, can be serious”, and the bottle's own three-part caution.

None are published for this formula and no trial exists to establish any. From our sources on individual ingredients: NCCIH records “a number of cases that link liver injury to ashwagandha supplements”, and that oral turmeric “can cause adverse effects such as nausea and vomiting, acid reflux, stomach upset, diarrhea, or constipation.” The amounts here are 25 mg each. None of those notes is on the bottle.

Take the panel to whoever manages your prescriptions. Two specifics we can name: metformin and B12 (see above), and blood-sugar medication alongside 400 mg of alpha-lipoic acid, which is a conversation worth having rather than a documented interaction we can quote for you. The bottle's own caution covers anyone with a known medical condition, which on this product is most buyers.

If you have a liver condition, this is a question for a clinician. NCCIH records rare cases linking liver injury to ashwagandha supplements, and liver damage reported with highly bioavailable curcumin formulations — though this product uses plain root powder, which NCCIH calls “likely safe… in the recommended amounts for up to 2 or 3 months.” Both ingredients here are 25 mg.

The bottle's own caution says pregnant or nursing mothers should consult a physician before using this or any dietary supplement. NCCIH adds specifically that turmeric supplements “during pregnancy may be unsafe.”

No. The bottle's caution names children under 18 explicitly.

Most of the research behind the two best-dosed ingredients was done in people with diabetic peripheral neuropathy, so the trials are closer to your situation than to anyone else's. That is a reason to read them carefully, not a reason to buy without asking. NCCIH's summary of the whole category is “for most supplements… there isn't evidence to support a beneficial effect on diabetes or its complications.” And if you take metformin, read the B12 question first.

The trials cited on this site are in diabetic peripheral neuropathy, not in chemotherapy-induced neuropathy. They are different conditions with different mechanisms, and we have not found and do not cite evidence for this formula in the second. If you are in or after cancer treatment, anything you add is a question for your oncology team before it is a question for a label.

If numbness or tingling is new, spreading, affecting your balance, or has gone on for weeks without anyone looking at it. Diabetic, B12-deficiency, compressive and chemotherapy-induced neuropathies are different problems with different answers, and only one of them is plausibly touched by anything in this bottle. The useful first step is finding out which one you have.

One bottle $69. Three bottles at $59 each, $177. Six bottles at $49 each, $294, with free-shipping copy on the three- and six-bottle packs. At two capsules a day a bottle is thirty days, so that works out at $2.30, $1.97 and $1.63 a day. There is no struck-through “was” figure anywhere, which is rarer and better than it sounds.<p>One caveat worth knowing: the product pack supplied to this desk contains no price at all and instructs us to print whatever the live checkout prints. These figures were confirmed separately. Check the checkout before you pay.</p>

180 days, money back. The seal supplied with this product says MONEY BACK · 180 DAYS · GUARANTEE, and a full guarantee panel in the same pack says Test-Drive Nerve Recovery Max Risk-Free for 180 Days and we'll refund every penny.<p>Two things to know before you rely on it. The written brief in the same pack declines to state a length at all and defers to the live checkout — so read the window on the checkout screen and screenshot it. And refund every penny sits beside a brief that says the buyer pays return shipping. Those are not the same promise.</p>

Three, if you buy at all. At $1.97 a day it is 15% cheaper than a single bottle, it carries free shipping, it covers both of the trials behind this formula several times over, and ninety days is the longest NCCIH describes ashwagandha as safe for. It is also what seven of the ten supplied reviews bought.<p>The six-bottle pack is $1.63 a day, cheaper still — but it is six months, twice that ashwagandha period, and 180 days of supply against a 180-day window, so the last bottle opens on the day the window closes.</p>

This site's buy buttons go to the checkout we were given. Before you use any link for a product like this, check the address printed on the bottle: this one prints nerverecoverymax.com and (888) 869-0440. A search for this product name returns a crowd of different domains presenting themselves as the official website, several of which misspell the brand name. The printed label is the thing to trust.

A search returns an Amazon listing for a product of this name. We could not open it — Amazon refuses automated requests — so we cannot tell you who sells it there, what it costs, or whether it is the same formula, and we are not going to describe a listing we have not read. Where a supplement is bought matters: a marketplace sets its own return window, which is not whatever the checkout's is.

The bottle prints nerverecoverymax.com. That is the address the manufacturer put on the product, and it is the one we would start from. A search for this brand returns many other domains describing themselves as the official website, including some that spell the brand name differently. This site is a U.S. desk for the product, not the brand's own site, and it says so at the top of every page.

Not published to us. Check the checkout screen before you pay, and look specifically for a pre-ticked box or a trial that converts. We cannot tell you there is not one.

Ships from the United States unless the sales page says otherwise, with a tracking number in the order email. The three- and six-bottle packs carry free-shipping copy; nothing was published for the single bottle, so check what it adds before comparing $69 against $177. Speed, carrier and international availability were not published.

Call the order desk on +1 (302) 200-3480 with your order ID, or email [email protected]. Returns go to 712 Fifth Avenue, Floor 8, New York, NY 10019, with your full name, the email on the order and the order ID inside the parcel. Return shipping is paid by you — use tracking. Expect 3–5 business days for them to credit it and another 5–10 for the card. The length of the window itself is not published to us.

+1 (302) 200-3480 for anything about an order — tracking, changes, refunds — with your order ID ready. The number printed on the bottle, (888) 869-0440, belongs to the distributor in Akron, Ohio. They are different companies and only one of them can see your order.

Nerverecovery-max is a U.S. desk for Nerve Recovery Max, with offices at 205 Hudson Street, Floor 7, New York, NY 10013 and returns at 712 Fifth Avenue, Floor 8, New York, NY 10019. We are not the manufacturer. The only company named on the bottle is Nerve Recovery Max of Akron, Ohio.

Yes. Orders placed through the buy buttons here earn this site a commission, and that is the whole of our funding model. It is also why the two lines on this label that do not survive a check are at the top of the page rather than the bottom.

The Nerverecovery-max Editorial Desk. We read the printed panel at native resolution, recomputed all four percentages on it, and put every printed amount beside the dose a published trial actually used.

No, and every reviewer slot on this site is deliberately left blank to say so. A podiatrist's name was supplied to us with the product pack, with instructions to print it as the medical reviewer in the footer, on the about page and on the journal posts. He has not read these pages — they were written after the pack arrived. Printing his name would assert a professional endorsement that has not happened. When a named clinician has actually reviewed a page, the name and the date go in and the highlight disappears.

We cannot tell you, and we will not pretend otherwise. All ten reviews, the 4.4 score, the star distribution and the order count were supplied to this desk in the same pack as the label artwork. We did not collect them, cannot contact the people named, and cannot confirm that any portrait is a photograph of that person. We publish them in full and unedited with that said plainly on every card — and we note that the distribution supplied works out to 4.3, not the 4.4 printed beside it.

Because we do not put one in the code. Google's guidance says ratings “must be sourced directly from users” and that a page is ineligible where “the entity that's being reviewed controls the reviews about itself.” These came from the brand, so this site emits no Review or AggregateRating structured data on any page.

Each one marks a value a human has to supply before this site goes live — a price, a guarantee length, a reviewer's name. We would rather show you where a number is missing than borrow one from somewhere else and present it as the checkout's. There are more of them on this site than on any we have built, because the pack we were given contained no prices and no guarantee terms at all.